Drug use associated tricuspid valve infective endocarditis in pregnancy. uri icon

Overview

abstract

  • BACKGROUND AND AIM: We report a case of intravenous drug use associated tricuspid valve endocarditis in a 28-year-old pregnant female at 26-week gestation. METHODS: Patient management required a multidisciplinary collaboration between cardiac surgery, obstetrics and gynecology, and neonatal critical care. RESULTS: Despite appropriate intravenous antibiotics, the patient developed life-threatening complications and underwent planned cesarean delivery at 28 weeks 6 days gestation followed by interval tricuspid valve replacement 1 week later. CONCLUSIONS: Both the patient and her infant were successfully managed through the perioperative period.

publication date

  • July 27, 2020

Research

keywords

  • Cardiac Surgical Procedures
  • Endocarditis
  • Endocarditis, Bacterial
  • Pharmaceutical Preparations

Identity

Scopus Document Identifier

  • 85088579909

Digital Object Identifier (DOI)

  • 10.1111/jocs.14888

PubMed ID

  • 32720414

Additional Document Info

volume

  • 35

issue

  • 9